- Home
- PBYI vs SLND Comparison
PBYI vs SLND Comparison
Compare PBYI & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- SLND
- Stock Information
- Founded
- PBYI 2010
- SLND 1900
- Country
- PBYI United States
- SLND United States
- Employees
- PBYI N/A
- SLND N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- PBYI Health Care
- SLND Industrials
- Exchange
- PBYI Nasdaq
- SLND Nasdaq
- Market Cap
- PBYI 164.3M
- SLND 175.8M
- IPO Year
- PBYI N/A
- SLND N/A
- Fundamental
- Price
- PBYI $3.54
- SLND $4.49
- Analyst Decision
- PBYI Strong Buy
- SLND Strong Buy
- Analyst Count
- PBYI 1
- SLND 1
- Target Price
- PBYI $7.00
- SLND $5.00
- AVG Volume (30 Days)
- PBYI 306.9K
- SLND 72.4K
- Earning Date
- PBYI 07-31-2025
- SLND 08-11-2025
- Dividend Yield
- PBYI N/A
- SLND N/A
- EPS Growth
- PBYI 143.51
- SLND N/A
- EPS
- PBYI 0.77
- SLND N/A
- Revenue
- PBYI $232,709,000.00
- SLND $931,568,000.00
- Revenue This Year
- PBYI N/A
- SLND $3.76
- Revenue Next Year
- PBYI N/A
- SLND $1.08
- P/E Ratio
- PBYI $4.64
- SLND N/A
- Revenue Growth
- PBYI 2.68
- SLND N/A
- 52 Week Low
- PBYI $2.23
- SLND $1.85
- 52 Week High
- PBYI $4.13
- SLND $4.62
- Technical
- Relative Strength Index (RSI)
- PBYI 58.61
- SLND 71.29
- Support Level
- PBYI $3.26
- SLND $3.66
- Resistance Level
- PBYI $3.65
- SLND $4.62
- Average True Range (ATR)
- PBYI 0.14
- SLND 0.26
- MACD
- PBYI 0.01
- SLND 0.05
- Stochastic Oscillator
- PBYI 84.78
- SLND 87.04
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.